Trial intelligence / Profile preview

Direct vs Indirect Effects of Intranasal Oxytocin

NCT04134663Completed

Sponsor
University of Electronic Science and Technology of China
Start
Mar 2019
Primary completion
Jun 2021
Modality
Peptides
Countries
1
01

Overview

Randomised, double-blind trial of oxytocin in psychiatric disorders (3 arms), sponsored by University of Electronic Science and Technology of China. Primary endpoints: blood oxytocin concentration at 2 hours and resting EEG time-frequency at 2 hours. Started Mar 2019; status: completed.

02

Drugs

oxytocin
03

Conditions

psychiatric disorders

Beyond the preview

Go deeper on NCT04134663.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04134663.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call